Cargando…
Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV–Co-Infected Patients
Tuberculosis (TB) and HIV co-infection claims many lives every year. This study assessed immune responses in Mycobacterium tuberculosis–infected lymph node tissues from HIV-negative and HIV-positive patients compared with the peripheral circulation with a focus on myeloid cells and the cell-signalin...
Autores principales: | Ashenafi, Senait, Muvva, Jagadeeswara Rao, Mily, Akhirunnesa, Snäll, Johanna, Zewdie, Martha, Chanyalew, Menberework, Rehn, Anders, Rahman, Sayma, Aseffa, Getachew, Bekele, Amsalu, Aderaye, Getachew, Lema, Beede, Svensson, Mattias, Brighenti, Susanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Investigative Pathology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302207/ https://www.ncbi.nlm.nih.gov/pubmed/35092727 http://dx.doi.org/10.1016/j.ajpath.2021.12.013 |
Ejemplares similares
-
Vitamin D(3) Status and the Association with Human Cathelicidin Expression in Patients with Different Clinical Forms of Active Tuberculosis
por: Ashenafi, Senait, et al.
Publicado: (2018) -
BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients
por: Ashenafi, Senait, et al.
Publicado: (2013) -
Anemia Is a Strong Predictor of Wasting, Disease Severity, and Progression, in Clinical Tuberculosis (TB)
por: Ashenafi, Senait, et al.
Publicado: (2022) -
Daily Nutritional Supplementation with Vitamin D(3) and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial
por: Ashenafi, Senait, et al.
Publicado: (2019) -
Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1
por: Missailidis, Catharina, et al.
Publicado: (2019)